European health officials have advocated portfolio diversity to help fight different variants
Biontech
Chief executive says draft plan to cut market exclusivity protection could make pursuing some treatments unviable
Sales drop 43% in third quarter as primary immunisation drives reach completion
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs
Group still expects to hit a target of €13-17bn in vaccine revenues this year, with demand increasing in the fourth quarter
Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority
Recommendation comes as global cases of virus top 500m amid Omicron surge
Cantillon: Emerging markets surprise observers with vaccine preferences
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Another 11,671 PCR-confirmed coronavirus cases reported in past few days
Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages
Companies to test fourth dose of current vaccine against fourth dose of new one
YOU MAY ALSO LIKE...
Inquests into the nightclub fire that led to the deaths of 48 people
A project examining attitudes about the future of Ireland
Weddings, Births, Deaths and other family notices